Have a personal or library account? Click to login
Movement Disorders in Toxoplasmosis: A Systematic Review Cover

Movement Disorders in Toxoplasmosis: A Systematic Review

Open Access
|Sep 2025

References

  1. 1Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis. Clin Microbiol Rev. 2020;34(1):e0011519. DOI: 10.1128/CMR.00115-19
  2. 2Amod F, Holla VV, Ojha R, Pandey S, Yadav R, Pal PK. A review of movement disorders in persons living with HIV. Parkinsonism Relat Disord. 2023;114:105774. DOI: 10.1016/j.parkreldis.2023.105774
  3. 3Carroll E, Sanchez-Ramos J. Hyperkinetic movement disorders associated with HIV and other viral infections. Handb Clin Neurol. 2011;100:32334. DOI: 10.1016/B978-0-444-52014-2.00025-2
  4. 4Pedroso JL, Vale TC, Gama MTD, Ribas G, Kristochik JCG, Germiniani FMB, Fink MCDDS, Oliveira ACP, Teive HAG, Barsottini OG. Cerebellar degeneration and progressive ataxia associated with HIV-virus infection. Parkinsonism Relat Disord. 2018;54:9598. DOI: 10.1016/j.parkreldis.2018.04.007
  5. 5Nath A, Hobson DE, Russell A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord. 1993;8(1): 10712. DOI: 10.1002/mds.870080119
  6. 6Garg RK, Pandey S, Singhal S. Toxoplasmosis-Associated Extrapyramidal and Movement Disorders: A Systematic Review. PROSPERO 2025 CRD420251119727. Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251119727.
  7. 7Aerts R, Mehra V, Groll AH, Martino R, Lagrou K, Robin C, Perruccio K, Blijlevens N, Nucci M, Slavin M, Bretagne S, Cordonnier C, European Conference on Infections in Leukaemia group. Guidelines for the management of Toxoplasma gondii infection and disease in patients with haematological malignancies and after haematopoietic stem-cell transplantation: guidelines from the 9th European Conference on Infections in Leukaemia, 2022. Lancet Infect Dis. 2024;24(5):e291e306. DOI: 10.1016/S1473-3099(23)00495-4
  8. 8Hey G, Hu W, Wong J, Tsuboi T, Burns MR, Ramirez-Zamora A. Evolving Concepts in Our Understanding and Treatment of Holmes Tremor, Over 100 Years in the Making. Tremor Other Hyperkinet Mov (N Y). 2022;12:18. DOI: 10.5334/tohm.683
  9. 9The Movement Disorder Society. About Movement Disorders: View clinical information, resources, tools and education about common movement disorders. Downloaded from https://www.movementdisorders.org/MDS/About/Movement-Disorder-Overviews.htm. Assessed on 31th July, 2025.
  10. 10Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):6063. DOI: 10.1136/bmjebm-2017-110853
  11. 11Della Gatta AN, Rizzo R, Pilu G, Simonazzi G. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 2020;223(1):3641. DOI: 10.1016/j.ajog.2020.04.013
  12. 12Alves D, Sobrosa P, Morais Passos R, Silva F, Ferreira A, Corga da Silva R, Silva D. Cerebral Toxoplasmosis Mimicking a Brain Neoplasm in an Inaugural HIV-Positive Patient: The Importance of Early Decision-Making and Background Assessment in the Emergency Department. Cureus. 2025;17(1):e76936. DOI: 10.7759/cureus.76936
  13. 13Diaz MM, McCutchan JA, Crescini M, Tang B, Franklin D, Letendre SL, Heaton RK, Bharti AR. Longitudinal study of cognitive function in people with HIV and toxoplasmic encephalitis or latent toxoplasma infection. AIDS. 2024;38(15):20212029. DOI: 10.1097/QAD.0000000000003992
  14. 14Hoover EM, Schneider CA, Crouzet C, Lima TS, Velez DXF, Tran CJ, Agalliu D, Gandhi SP, Choi B, Lodoen MB. Infection with Toxoplasma gondii triggers coagulation at the blood-brain barrier and a reduction in cerebral blood flow. J Neuroinflammation. 2025;22(1):3. DOI: 10.1186/s12974-024-03330-1
  15. 15Johnson HJ, Kochanowsky JA, Chandrasekaran S, Hunter CA, Beiting DP, Koshy AA. Defining neuronal responses to the neurotropic parasite Toxoplasma gondii. mSphere. 2025;10(6):e0021625. DOI: 10.1128/msphere.00216-25
  16. 16Kavakebian M, Ghandali T, Nasiri H, Ramezani-Moghadam F, Alizadeh S, Alizadeh S, Silakhor M, Rajabi M, Mirmazhari A, Asgarian P, Rahimi H, Karimi M, Moosazadeh M. The cognitive and neurological implications of toxoplasma gondii infection: Evidence from a systematic review and meta-analysis. Acta Trop. 2025;268:107705. DOI: 10.1016/j.actatropica.2025.107705
  17. 17Zhou Z, Zhou R, Li K, Wei W, Zhang Z, Zhu Y, Luan R. The Association between Toxoplasma gondii Infection and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2019;2019:8186017. DOI: 10.1155/2019/8186017
  18. 18Fallahi S, Rostami A, Birjandi M, Zebardast N, Kheirandish F, Spotin A. Parkinson’s disease and Toxoplasma gondii infection: Sero-molecular assess the possible link among patients. Acta Trop. 2017;173:97101. DOI: 10.1016/j.actatropica.2017.06.002
  19. 19Alvarado-Esquivel C, Méndez-Hernández EM, Salas-Pacheco JM, Ruano-Calderón LÁ, Hernández-Tinoco J, Arias-Carrión O, Sánchez-Anguiano LF, Castellanos-Juárez FX, Sandoval-Carrillo AA, Liesenfeld O, Ramos-Nevárez A. Toxoplasma gondii exposure and Parkinson’s disease: a case-control study. BMJ Open. 2017;7(2):e013019. DOI: 10.1136/bmjopen-2016-013019
  20. 20Celik T, Altunisik E, Yar TM, Gul T, Kasko Arici Y, Karaman U. A new perspective on essential tremor: the potential etiologic role of Toxoplasma gondii and Toxocara spp. Int J Environ Health Res. 2025;35(7):17641771. DOI: 10.1080/09603123.2024.2404480
  21. 21Taherianfard M, Riyahi M, Razavi M, Bavandi Z, Eskandari Roozbahani N, Namavari MM. The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson’s Disease Can Be Affected by Toxoplasma gondii Infection. Biomed Res Int. 2020;2020:2546365. DOI: 10.1155/2020/2546365
  22. 22Mohammadzadeh N, Tung GA, Prakash P, Alhusaini S. Parkinsonism: A Rare Complication of Cerebral Toxoplasmosis. Ann Neurol. 2023;94(5):917918. DOI: 10.1002/ana.26777
  23. 23Malaquias MJ, Magrinelli F, Quattrone A, Neo RJ, Latorre A, Mulroy E, Bhatia KP. Presynaptic Hemiparkinsonism Following Cerebral Toxoplasmosis: Case Report and Literature Review. Mov Disord Clin Pract. 2022;10(2):285299. DOI: 10.1002/mdc3.13631
DOI: https://doi.org/10.5334/tohm.1093 | Journal eISSN: 2160-8288
Language: English
Submitted on: Aug 17, 2025
Accepted on: Sep 20, 2025
Published on: Sep 30, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Ravindra Kumar Garg, Shweta Pandey, Manoj Agarwal, Sanjay Singhal, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.